menu search

VTGN / Vistagen Therapeutics, Inc. (VTGN) Q1 2024 Earnings Call Transcript

Vistagen Therapeutics, Inc. (VTGN) Q1 2024 Earnings Call Transcript
Vistagen Therapeutics, Inc. (NASDAQ:VTGN ) Q1 2024 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Mark Flather - VP of IR Shawn Singh - CEO Josh Prince - SVP of Business Operations Conference Call Participants Andrew Tsai - Jefferies Joanne Lee - Maxim Group Operator Greetings, and welcome to the Vistagen Therapeutics Fiscal Year 2024 First Quarter Corporate Update Conference Call. [Operator Instructions] And as a reminder, this conference is being recorded, Thursday, August 10, 2023. Read More
Posted: Aug 13 2023, 05:24
Author Name: Seeking Alpha
Views: 121271

VTGN News  

Vistagen Therapeutics, Inc. (VTGN) Q1 2024 Earnings Call Transcript

By Seeking Alpha
August 13, 2023

Vistagen Therapeutics, Inc. (VTGN) Q1 2024 Earnings Call Transcript

Vistagen Therapeutics, Inc. (NASDAQ:VTGN ) Q1 2024 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Mark Flather - VP of IR Sh more_horizontal

Outperforming Biotech Pops on Shareholder Buzz

By Schaeffers Research
August 10, 2023

Outperforming Biotech Pops on Shareholder Buzz

Vistagen Therapeutics Inc (NASDAQ:VTGN) is continuing its recent volatility, after today's news that healthcare investment name Commodore Capital Mast more_horizontal

Why Is Vistagen Therapeutics (VTGN) Stock Up 650% Today?

By InvestorPlace
August 7, 2023

Why Is Vistagen Therapeutics (VTGN) Stock Up 650% Today?

Vistagen Therapeutics (NASDAQ: VTGN ) stock is surging to impressive levels today on news of some positive trial results. The pharmaceutical producer more_horizontal

VistaGen Therapeutics (VTGN Stock) Exploded 3,471% Here's Why

By PennyStocks
August 7, 2023

VistaGen Therapeutics (VTGN Stock) Exploded 3,471% Here's Why

Are you looking for penny stocks to buy? Are you grappling with the push and pull of skeptics saying penny stocks aren't worth it or penny stocks are more_horizontal

Vistagen to Announce Fiscal Year 2023 Financial Results and Provide Corporate Update Conference Call on June 28, 2023

By Business Wire
June 27, 2023

Vistagen to Announce Fiscal Year 2023 Financial Results and Provide Corporate Update Conference Call on June 28, 2023

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VTGN #mentalhealth--Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming more_horizontal

VistaGen Therapeutics, Inc. (VTGN) Q3 2023 Earnings Call Transcript

By Seeking Alpha
February 10, 2023

VistaGen Therapeutics, Inc. (VTGN) Q3 2023 Earnings Call Transcript

VistaGen Therapeutics, Inc. (NASDAQ:VTGN ) Q3 2023 Earnings Conference Call February 7, 2023 5:00 PM ET Company Participants Mark Flather - Vice Presi more_horizontal

VistaGen Therapeutics, Inc. (VTGN) Reports Q3 Loss, Misses Revenue Estimates

By Zacks Investment Research
February 7, 2023

VistaGen Therapeutics, Inc. (VTGN) Reports Q3 Loss, Misses Revenue Estimates

VistaGen Therapeutics, Inc. (VTGN) delivered earnings and revenue surprises of 16.67% and 41.94%, respectively, for the quarter ended December 2022. D more_horizontal

Vistagen to Report Fiscal Year 2023 Third Quarter Financial Results on February 7, 2023

By Business Wire
February 6, 2023

Vistagen to Report Fiscal Year 2023 Third Quarter Financial Results on February 7, 2023

SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )--Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treat more_horizontal


Search within

Pages Search Results: